rAAVen Therapeutics

rAAVen Therapeutics is an AAV engineering company focused on generating novel vectors for next-generation gene therapies. The company's unique AAV development platform, which integrates state-of-the-art methods in cloning, viral vector production, and next-generation sequencing, streamlines processes, increases success rates, and enhances translational value. rAAVen's mission is to address all areas of AAV engineering to achieve increased cell specificity, target new cell types, enhance infectivity, evade antibodies, and increase payload capacity.